-
Posted by
Two Blokes Mon at 11:15 AM -
Filed in
Stock
-
1 view
Multiple doses of APG808 resulted in rapid suppression of FeNO, a biomarker of Type 2 inflammation associated with exacerbations in asthma, with a robust maximal FeNO decrease from baseline of 53%
